Man Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.8M Buy
127,618
+112,434
+740% +$50.1M 0.11% 194
2025
Q1
$7.36M Sell
15,184
-73,542
-83% -$35.7M 0.02% 723
2024
Q4
$35.7M Buy
88,726
+37,008
+72% +$14.9M 0.09% 221
2024
Q3
$24.1M Sell
51,718
-145,578
-74% -$67.7M 0.06% 363
2024
Q2
$92.5M Sell
197,296
-330,628
-63% -$155M 0.23% 91
2024
Q1
$221M Buy
527,924
+173,126
+49% +$72.4M 0.56% 19
2023
Q4
$144M Buy
+354,798
New +$144M 0.4% 39
2023
Q3
Sell
-382,820
Closed -$135M 68
2023
Q2
$135M Buy
+382,820
New +$135M 0.42% 36
2023
Q1
Sell
-576,398
Closed -$166M 46
2022
Q4
$166M Buy
576,398
+340,716
+145% +$98.4M 0.6% 19
2022
Q3
$68.2M Buy
+235,682
New +$68.2M 0.32% 59
2022
Q2
Sell
-430,760
Closed -$112M 159
2022
Q1
$112M Sell
430,760
-532,765
-55% -$139M 0.39% 41
2021
Q4
$212M Sell
963,525
-247,918
-20% -$54.4M 0.68% 19
2021
Q3
$220M Buy
1,211,443
+371,319
+44% +$67.4M 0.77% 14
2021
Q2
$169M Buy
840,124
+202,762
+32% +$40.9M 0.6% 19
2021
Q1
$137M Sell
637,362
-290,549
-31% -$62.4M 0.6% 20
2020
Q4
$219M Buy
927,911
+217,679
+31% +$51.4M 0.96% 10
2020
Q3
$193M Buy
710,232
+117,797
+20% +$32.1M 0.76% 15
2020
Q2
$172M Sell
592,435
-75,565
-11% -$21.9M 0.87% 16
2020
Q1
$159M Buy
668,000
+431,635
+183% +$103M 1.03% 12
2019
Q4
$51.8M Buy
236,365
+171,786
+266% +$37.6M 0.17% 120
2019
Q3
$10.9M Sell
64,579
-67,846
-51% -$11.5M 0.04% 543
2019
Q2
$24.3M Buy
132,425
+25,460
+24% +$4.67M 0.09% 280
2019
Q1
$19.7M Sell
106,965
-123,977
-54% -$22.8M 0.07% 320
2018
Q4
$38.3M Buy
230,942
+135,385
+142% +$22.4M 0.17% 127
2018
Q3
$18.4M Sell
95,557
-40,728
-30% -$7.85M 0.07% 347
2018
Q2
$23.2M Buy
136,285
+23,668
+21% +$4.02M 0.1% 220
2018
Q1
$18.4M Buy
+112,617
New +$18.4M 0.08% 255